Solifenacin Succinate Tablet, Film Coated
Product Images NDC 60505-4703

3 FDA label images from Apotex Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Solifenacin Succinate (NDC 60505-4703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Image 01
Chemical structure diagram of solifenacin succinate, the active ingredient.*
FDA Label Image

Image Description (Solifenacin 02)

Image Description (Solifenacin 02)
Label for Solifenacin Succinate Tablets 5 mg by Apotex Corp., showing a package of 30 film-coated oral tablets. The label includes dosing information for 5 mg strength, storage instructions, manufacturer details (Qilu Pharmaceutical Co., Ltd., China), and the NDC number 60505-4702-3.*
FDA Label Image

Image Description (Solifenacin 03)

Image Description (Solifenacin 03)
Label for Solifenacin Succinate Tablets 10 mg by Apotex Corp. The film-coated oral tablets are supplied in a bottle of 30 tablets. The label includes dosage instructions as once daily, manufacturer information, as well as lot, expiration, and serial number placeholders. The NDC number is 60505-4703-3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.